Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 October, 2018 11:16 IST
Dr. Reddy's Lab gets EIR from USFDA for Hyderabad facility
Source: IRIS | 12 Dec, 2017, 09.50AM
Comments  |  Post Comment

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food & Drug Administration (USFDA) for its Formulations Manufacturing Plant-3 at Bachupally, Hyderabad as closure of audit.

Earlier in April, USFDA had inspected the Formulations Manufacturing Plant-3 wherein it had issued a form 483 with 11 observations.

The stock had underperformed the market over the past one month till Dec. 11, 2017, falling 6.84% compared with the Sensex's 0.42% rise. It underperformed the market in past one quarter, gaining 1.22% as against 4.94% rise in the Sensex.

Shares of the company gained Rs 88.45, or 4.03%, to trade at Rs 2,281.95. The total volume of shares traded was 41,519 at the BSE (9.39 a.m., Tuesday).

Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Glenmark Pharma to present data on investigational treatment for Atopic Dermatitis - 19-Oct-2018 09:55
Zydus receives tentative approval from USFDA for Colchicine Tablets - 18-Oct-2018 16:21
Ramco Systems partners with Airbus Helicopters SAS - 18-Oct-2018 10:26
ABB bags transformer order worth Rs 1.15 bn from Indian Railways - 18-Oct-2018 10:20
Zydus Cadila gets nod for Clobetasol propionate cream - 17-Oct-2018 15:19
Aurionpro Solutions to acquire majority stake in Singapore based SC Soft - 17-Oct-2018 13:26
Adani Group partners with Total to provide multi-energy offering - 17-Oct-2018 13:16
Sterlite Tech wins Rs 35 bn contract for Indian Navy's digital network - 16-Oct-2018 11:03
Lupin receives tentative approval for generic Lurasidone HCl tablets - 16-Oct-2018 09:42
Glenmark Pharma gets nod for Hydrocortisone Valerate cream - 16-Oct-2018 09:25
Shriram Transport to raise upto Rs 13.50 bn via NCDs - 15-Oct-2018 10:29
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer